Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 12:00AM GMT
Release Date Price: €98.52 (+0.24%)
Joanna Sylvia Gajuk
BofA Merrill Lynch, Research Division - VP

Thank you so much for sticking out here with us. My name is Joanna Gajuk. I cover some of the post-acute care companies at Bank of America. So now we're going to hear from Amedisys, one of the largest home health and hospice providers in the U.S.

And today, we have Paul Kusserow with us here, President and CEO, but also Chris, who's joining us here on the stage. And in the room also are Nick and Mike here, but the gentlemen here agreed to go right into Q&A. So I'll lead up with some questions. But please feel free to chime with any questions you have on your mind.

Questions & Answers

Joanna Sylvia Gajuk
BofA Merrill Lynch, Research Division - VP

So I'll start with the obvious topic, PDGM.

Paul Berthold Kusserow
Amedisys, Inc. - Chairman, President & CEO

Sure. Wonderful. Surprised.

Joanna Sylvia Gajuk
BofA Merrill Lynch, Research Division - VP

Right. Surprise, surprise.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot